NPPA reduces Prices of 9 Non-Scheduled Cancer Drugs by 87%

The National Pharmaceutical Pricing Authority (NPPA) has reduced the prices of 9 non-scheduled cancer drugs by up to 87%. This decision is in continuation of nodal agency’s efforts to bring down drugs prices. Key Facts Reason: In February 2019, the ..

Tags: Anti-cancer drugs • Cancer drugs • Department of Pharmaceuticals • Drug Price Control Orders • Drug Pricing

Month: Current Affairs - May, 2019

China, India clinch deal to reduce tariffs on Indian medicines, anti-cancer drugs

China has announced that it has clinched deal with India on reduction of tariffs (import duties) on Indian medicines including anti-cancer drugs. However, it is not yet clear whether it has agreed to grant licences to Indian companies to sell ..

Tags: Anti-cancer drugs • Business • India China • Pharmaceutical Sector • Trade

Month: Current Affairs - July, 2018